In support of this, data analyzed from Oncomine revealed a trend towards decreased expression of SIN3A and increased expression of SIN3B in patients with triple negative invasive ductal carcinoma compared to ductal carcinoma in situ. Here, SIN3B is linked to invasive ductal breast carcinoma.